This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for EXAS to draw a line in its place.
EXAS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 19 November 2025.
DateInsiderTypeSharesValue
19 Nov 2025ORVILLE JACOB AEVP, GM, ScreeningSell5,000$375K
19 Nov 2025Herriott JamesSVP, General Counsel & SecSell1,000$70K
04 Nov 2025Baranick BrianEVP, GM, Precision OncologySell2,858$200K
04 Nov 2025Herriott JamesSVP, General Counsel & SecSell1,500$105K
24 Oct 2025Zanotti Katherine SSell12,000$780K
09 Oct 2025Doyle James EdwardSell2,000$120K
09 Oct 2025Herriott JamesSVP, General Counsel & SecSell1,500$90K
13 Aug 2025Doyle James EdwardSell1,485$62K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
05 Aug 2025Baranick BrianEVP, GM, Precision OncologyTax withheld2,717$127K
05 Aug 2025ORVILLE JACOB AEVP, GM, ScreeningTax withheld2,515$118K
05 Aug 2025Baranick BrianEVP, GM, Precision OncologyOption exercise5,350
05 Aug 2025ORVILLE JACOB AEVP, GM, ScreeningOption exercise5,350